论文部分内容阅读
目的:探析疏肝和胃法配合奥美拉唑治疗肝气犯胃型消化性溃疡的临床效果。方法:回顾相关资料,选取我院2013年5月至2016年5月收治的肝气犯胃型消化性溃疡患者60例,由于治疗的方式不同,随机分为对照组和实验组各30例,所有患者均给予基础治疗,对照组加用奥美拉唑进行治疗,实验组则疏肝和胃法+奥美拉唑进行治疗,对比各组间患者的治疗效果、不良反应的发生情况以及复发率。结果:进行不同的药物治疗后,患者的临床效果各不相同,其中实验组的治疗总有效率远高于对照组,且不良反应的发生情况和复发率均明显低于对照组,各组间的数据结果进行比较后,存在一定的差异性,具有统计学意义(P<0.05)。结论:针对消化道溃疡患者应用疏肝和胃法+奥美拉唑进行治疗的临床效果显著,不仅降低了不良反应的发生率,减少了复发率和病死率,而且提高了患者的生活质量,具有一定的可行性,值得患者信赖和在临床中推广应用。
Objective: To explore the clinical effect of Shugan and Stomach combined with omeprazole in the treatment of stomach gas peptic ulcer caused by liver qi. Methods: According to the relevant data, we selected 60 patients with peptic ulcer caused by liver-gas instillation in our hospital from May 2013 to May 2016. Because of the different treatment methods, they were randomly divided into control group and experimental group of 30 cases. Patients were given basic treatment, the control group plus omeprazole treatment, the experimental group is Shugan and stomach + omeprazole treatment, the treatment of patients in each group compared the incidence of adverse reactions and the recurrence rate . Results: The clinical effects of patients after treatment were different, and the total effective rate of the experimental group was much higher than that of the control group, and the occurrence and recurrence rate of adverse reactions were significantly lower than those of the control group After comparing the data results, there are some differences, with statistical significance (P <0.05). Conclusion: The clinical effect of Shugan and Stomach + Omeprazole in patients with peptic ulcer is significant, which not only reduces the incidence of adverse reactions, reduces the recurrence rate and mortality, but also improves the quality of life of patients, Has a certain feasibility, it is worthy of patient trust and promotion in clinical application.